NPR

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday.

The U.S. Food and Drug Administration approved a label change requested by drugmaker Novo Nordisk that expands the use

You’re reading a preview, subscribe to read more.

More from NPR

NPR3 min read
US National Security Adviser And Saudi Arabia Crown Prince Hold Security Deal Talks
President Joe Biden's national security adviser met early Sunday with Saudi Arabia's Crown Prince Mohammed bin Salman to discuss a wide-ranging security agreement between the countries.
NPR2 min read
The Jawbone Of Washed-up Whale In New Zealand Was Removed With Chainsaw And Stolen
The jawbone of a nearly 50-foot sperm whale that washed ashore in New Zealand's southernmost region has been removed. While the act is illegal, it's also considered disrespectful to the Māori people.
NPR4 min read
At Morehouse, Biden Says Dissent Should Be Heard Because Democracy Is 'Still The Way'
Facing potential headwinds with both young voters and Black voters, President Biden's Morehouse College commencement address focused on his view of the importance - and future of - democracy.

Related Books & Audiobooks